Genomic correlates of clinical outcomes in patients with metastatic uveal melanoma (mUM) treated with tebentafusp (tebe)

dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorde la Cruz Merino, L.
dc.contributor.authorEroglu, Z.
dc.contributor.authorCollins, L.
dc.contributor.authorGreenshields-Watson, A.
dc.contributor.authorStanhope, S.
dc.contributor.authorAbdullah, S.
dc.contributor.authorRanade, K.
dc.contributor.authorSacco, J.
dc.contributor.authoraffiliation[de la Cruz Merino, L.] Hosp Univ Virgen Macarena, Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Eroglu, Z.] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA
dc.contributor.authoraffiliation[Collins, L.] Immunocore Ltd, Translat Med, Abingdon, Oxon, England
dc.contributor.authoraffiliation[Greenshields-Watson, A.] Immunocore Ltd, Translat Med, Abingdon, Oxon, England
dc.contributor.authoraffiliation[Stanhope, S.] Immunocore Ltd, Translat Med, Abingdon, Oxon, England
dc.contributor.authoraffiliation[Ranade, K.] Immunocore Ltd, Translat Med, Abingdon, Oxon, England
dc.contributor.authoraffiliation[Abdullah, S.] Immunocore Ltd, Clin Dev, Abingdon, Oxon, England
dc.contributor.authoraffiliation[Sacco, J.] Clatterbridge Canc Ctr NHS Fdn Trust, Clatterbridge Canc Ctr, Wirral, Merseyside, England
dc.contributor.funderImmunocore Ltd.
dc.date.accessioned2025-01-07T16:06:11Z
dc.date.available2025-01-07T16:06:11Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.1714
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.1714
dc.identifier.urihttps://hdl.handle.net/10668/27619
dc.identifier.wosID700527703314
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS1214-S1215
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleGenomic correlates of clinical outcomes in patients with metastatic uveal melanoma (mUM) treated with tebentafusp (tebe)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files